Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioRestorative Therapies, Inc.BRTX · Entity 8277 | 10% owner | October 28, 2024 | November 05, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioRestorative Therapies, Inc.
Report date October 28, 2024 · Filed November 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 445,933 |
Reported balance
After 2024-10-28 transaction · row 1
1 source rowRow 1 · 2024-10-28 · Sale · Disposed 1,112 · Balance 445,933 |
| Common StockSEC Table I · non-derivative | IndirectSee Fotenote | 477,972 |
Reported balance
Holding disclosure · report date 2024-10-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 477,972 F1: Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder. |
Filing footnotes · ownership attribution and instrument terms
F1: Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2022 Filed Mar 29, 2022 20:52 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 47,840 | $5.61 | $268,382.40 |
DisclosureSEC source: 0001567619-22-007664 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 249,824 F2 · price: This transaction was executed in multiple trades at prices ranging from $5.56 to $5.62 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: Owned by Fleetco, Inc. of which reporting person is sole shareholder. Read SEC document |
| March 01, 2022 Filed Mar 29, 2022 20:52 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 2,270 | $5.55 | $12,598.50 |
DisclosureSEC source: 0001567619-22-007664 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 201,984 F1 · ownership.nature: Owned by Fleetco, Inc. of which reporting person is sole shareholder. Read SEC document |
| January 06, 2020 Filed Jan 9, 2020 00:04 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 4,710,210 | $0.01 | $51,812.31 |
DisclosureSEC source: 0001567619-20-000794 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,823,795 F2 · price: This transaction was executed in multiple trades at prices ranging from $.0101 to $.0138 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Owned by Fleetco, Inc. of which reporting person is sole shareholder. Read SEC document |
| January 06, 2020 Filed Jan 9, 2020 00:04 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 3,750,000 | $0.01 | $51,000.00 |
DisclosureSEC source: 0001567619-20-000794 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,549,712 F1 · price: This transaction was executed in multiple trades at prices ranging from $.013 to $.0138 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 81,000 | $0.04 | $2,916.00 |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · nonDerivative · entry 12 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,113,585 F1 · ownership.nature: Owned by Fleetco, Inc. of which reporting person is sole shareholder. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 3,333,333 | Not disclosed Strike: $0.03 | Not disclosed |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · derivative · entry 22 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333,333 Underlying: Common Stock · 3,333,333 shares Expires 2024-10-16 F3 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 3,333,333 | Not disclosed Strike: $0.20 | Not disclosed |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · derivative · entry 21 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,333,333 shares Expires 2024-10-16 F3 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 555,555 | Not disclosed Strike: $0.03 | Not disclosed |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · derivative · entry 20 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,555 Underlying: Common Stock · 555,555 shares Expires 2024-05-07 F3 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 555,555 | Not disclosed Strike: $0.15 | Not disclosed |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · derivative · entry 19 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 555,555 shares Expires 2024-05-07 F3 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 555,556 | Not disclosed Strike: $0.03 | Not disclosed |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · derivative · entry 18 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,556 Underlying: Common Stock · 555,556 shares Expires 2024-05-07 F3 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 555,556 | Not disclosed Strike: $0.15 | Not disclosed |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · derivative · entry 17 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 555,556 shares Expires 2024-05-07 F3 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 500,000 | Not disclosed Strike: $0.03 | Not disclosed |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · derivative · entry 16 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2024-02-19 F3 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 500,000 | Not disclosed Strike: $0.15 | Not disclosed |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · derivative · entry 15 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500,000 shares Expires 2024-02-19 F3 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 500,000 | Not disclosed Strike: $0.03 | Not disclosed |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · derivative · entry 14 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2024-02-19 F3 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 500,000 | Not disclosed Strike: $0.15 | Not disclosed |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · derivative · entry 13 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500,000 shares Expires 2024-02-19 F3 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,010,085 | $0.03 | $32,423.73 |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · nonDerivative · entry 11 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,032,585 F2 · price: This transaction was executed in multiple trades at prices ranging from $.0279 to $.04 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: Owned by Fleetco, Inc. of which reporting person is sole shareholder. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 304,237 | $0.03 | $7,605.93 |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · nonDerivative · entry 10 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,799,712 Read SEC document |
| December 05, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 20,000 | $0.03 | $560.00 |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · nonDerivative · entry 9 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 22,500 F1 · ownership.nature: Owned by Fleetco, Inc. of which reporting person is sole shareholder. Read SEC document |
| December 05, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 223,030 | $0.03 | $5,575.75 |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · nonDerivative · entry 8 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,495,475 Read SEC document |
| December 05, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 7,649 | $0.03 | $221.82 |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · nonDerivative · entry 7 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,272,445 Read SEC document |
| December 04, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 200,000 | $0.03 | $6,000.00 |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · nonDerivative · entry 6 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,264,796 Read SEC document |
| December 04, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 92,351 | $0.03 | $2,724.35 |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · nonDerivative · entry 5 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,064,796 Read SEC document |
| November 21, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 58,000 | $0.05 | $2,900.00 |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · nonDerivative · entry 4 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,972,445 Read SEC document |
| November 21, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 80,000 | $0.05 | $3,920.00 |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · nonDerivative · entry 3 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,914,445 Read SEC document |
| November 15, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 10,000 | $0.07 | $740.00 |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,834,445 Read SEC document |
| October 28, 2019 Filed Nov 1, 2019 20:34 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,000 | $0.17 | $170.00 |
DisclosureSEC source: 0001567619-19-020298 · doc1.xml · nonDerivative · entry 5 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,824,445 Read SEC document |
| October 25, 2019 Filed Nov 1, 2019 20:34 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 151,000 | $0.14 | $21,728.90 |
DisclosureSEC source: 0001567619-19-020298 · doc1.xml · nonDerivative · entry 4 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,823,445 F2 · price: This transaction was executed in multiple trades at prices ranging from $0.14 to $0.15 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 23, 2019 Filed Nov 1, 2019 20:34 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 6,500 | $0.14 | $910.00 |
DisclosureSEC source: 0001567619-19-020298 · doc1.xml · nonDerivative · entry 3 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,672,445 Read SEC document |
| October 22, 2019 Filed Nov 1, 2019 20:34 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 36,213 | $0.14 | $5,069.82 |
DisclosureSEC source: 0001567619-19-020298 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,665,945 Read SEC document |
| October 21, 2019 Filed Nov 1, 2019 20:34 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 215,000 | $0.11 | $23,714.50 |
DisclosureSEC source: 0001567619-19-020298 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,629,732 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.10 to $0.13 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 30,000 | $0.12 | $3,600.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 24 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,414,732 Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseWarrant to acquire Common Stock · Derivative | 3,333,333 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · derivative · entry 33 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333,333 Underlying: Common Stock · 3,333,333 shares Expires 2024-10-16 Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 555,555 | Not disclosed Strike: $0.15 | Not disclosed |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · derivative · entry 32 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,555 Underlying: Common Stock · 555,555 shares Expires 2024-05-07 F9 · price: The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price and an extended expiration date. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 555,555 | Not disclosed Strike: $0.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · derivative · entry 31 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 555,555 shares Expires 2020-05-07 F9 · price: The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price and an extended expiration date. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 555,556 | Not disclosed Strike: $0.15 | Not disclosed |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · derivative · entry 30 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,556 Underlying: Common Stock · 555,556 shares Expires 2024-05-07 F8 · price: The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 555,556 | Not disclosed Strike: $0.85 | Not disclosed |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · derivative · entry 29 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 555,556 shares Expires 2024-05-07 F8 · price: The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 500,000 | Not disclosed Strike: $0.15 | Not disclosed |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · derivative · entry 28 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2024-02-19 F9 · price: The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price and an extended expiration date. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 500,000 | Not disclosed Strike: $0.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · derivative · entry 27 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500,000 shares Expires 2020-02-19 F9 · price: The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price and an extended expiration date. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 500,000 | Not disclosed Strike: $0.15 | Not disclosed |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · derivative · entry 26 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2024-02-19 F8 · price: The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | OtherWarrant to acquire Common Stock · Derivative | 500,000 | Not disclosed Strike: $0.85 | Not disclosed |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · derivative · entry 25 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500,000 shares Expires 2024-02-19 F8 · price: The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 3,333,333 | $0.15 | $499,999.95 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 23 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,384,732 F7 · shares: Private purchase from issuer. Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,000 | $0.15 | $150.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 22 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,051,399 Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 5,000 | $0.14 | $700.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 21 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,050,399 Read SEC document |
| October 14, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 13,000 | $0.11 | $1,430.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 20 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,045,399 Read SEC document |
| October 09, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 9,000 | $0.17 | $1,530.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 19 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032,399 Read SEC document |
| October 08, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 14,000 | $0.14 | $1,960.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 18 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,023,399 Read SEC document |
| October 08, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 61,971 | $0.13 | $8,056.23 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 17 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,009,399 F6 · balance_after: Gives effect to purchases made on August 21, 2019 and August 22, 2019 and reported on a separate Form 4 filed on August 23, 2019, as amended by a Form 4 filed on October 18, 2019. Read SEC document |
| August 22, 2019 Filed Aug 23, 2019 20:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 148,317 | $0.29 | $42,270.35 |
DisclosureSEC source: 0001567619-19-017528 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,614,529 F2 · price: This transaction was executed in multiple trades at prices ranging from $0.26 to $0.30 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 22, 2019 Filed Oct 18, 2019 20:05 UTC Amendment | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 130,120 | $0.28 | $37,006.13 |
DisclosureSEC source: 0001567619-19-019733 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,616,332 F1 · shares: The original Form 4 filed on August 23, 2019 is amended by this Form 4 to correctly reflect the number of shares acquired and the per share price for such date. F1 · price: The original Form 4 filed on August 23, 2019 is amended by this Form 4 to correctly reflect the number of shares acquired and the per share price for such date. F3 · price: This transaction was executed in multiple trades at prices ranging from $0.26 to $0.30 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Does not give effect to purchases made prior to such date and reported on Form 4 filed on October 18, 2019. Read SEC document |
| August 21, 2019 Filed Aug 23, 2019 20:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 26,700 | $0.26 | $6,893.94 |
DisclosureSEC source: 0001567619-19-017528 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,466,212 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.25 to $0.26 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.